Johanne Kaplan - 26 Oct 2023 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Development Officer
Signature
/s/ Max A. Milbury, Attorney-in-Fact for Johanne Kaplan
Issuer symbol
PMN
Transactions as of
26 Oct 2023
Net transactions value
$0
Form type
4
Filing time
30 Oct 2023, 19:46:32 UTC
Previous filing
16 Mar 2023
Next filing
20 Nov 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMN Option (right to buy) Award $0 +12,500 $0.000000 12,500 26 Oct 2023 Common Shares 12,500 $1.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option shall vest on October 26, 2024, and the balance shall vest ratably over 36 months.